London Business School
Tyler is a joint MD/MBA candidate at Harvard Medical School and London Business School, graduating in 2020. At Harvard, Tyler has focused on improving cancer care for patients both in the clinic and at the lab bench, where he studied a drug in clinical trial for stem cell transplants in leukemia and lymphoma. Prior to the MD/MBA, Tyler worked for two years as a project lead in oral cancer at the Centre for Stem Cells & Regenerative Medicine at King’s College London. He was also a 2012 Fulbright Scholar to Switzerland, where he improved skin stem cell technologies at l’École Polytechnique Fédérale de Lausanne. Tyler holds an MRes in Translational Cancer Medicine from King’s and a BS in Biology from Duke University.